A phase I study of HM781-36B, a novel pan-HER inhibitor, in patients (pts) with advanced solid tumors.
Tae Min Kim
No relevant relationships to disclose
Keun-Wook Lee
No relevant relationships to disclose
Do-Youn Oh
Research Funding - Preclinical research of HMB78136B
Jong-Seok Lee
No relevant relationships to disclose
Seock-Ah Im
Consultant or Advisory Role - Hanmi (U)
Dong-Wan Kim
No relevant relationships to disclose
Sae-Won Han
No relevant relationships to disclose
Yu Jung Kim
No relevant relationships to disclose
Tae-You Kim
Research Funding - Hanmi
Jee Hyun Kim
Research Funding - Hanmi
Kyung-Mi Park
Employment or Leadership Position - Clinical research director
Jeewoong Son
Employment or Leadership Position - Clinical research director
Yung-Jue Bang
Consultant or Advisory Role - Preclinical research
Honoraria - Preclinical research
Research Funding - Preclinical research